Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-01-19 @ 3:47 PM
Study NCT ID:
NCT02051751
Status:
COMPLETED
Last Update Posted:
2020-12-08
First Post:
2014-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-05
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-19
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-21
First Submit QC Date:
None
Study First Post Date:
2014-01-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-04
Last Update Post Date:
2020-12-08
Last Update Post Date Type:
ACTUAL